A Novel Approach for The Treatment of Viral Diseases - Part 2
These three ingredients of the composition according to the invention support intracellular immunity by enhancing the TH1 immune reaction. The composition according to the invention contains 1-protopanaxatriol, methylpanaxadiol, methylprotobioside. Said formulation is obtained by a mixture of the aforesaid components according to the following ratios by weight: 20-32% 1-protopanaxatriol, 30-47% methylpanaxadiol, 50-21% methylprotobioside. The composition is obtained from the aforesaid components selected from the aforesaid group and used according to the mentioned weight ratio ranges individually or in combinations. Said invention also encompasses the use of said composition for antiviral purpose and the manufacture thereof for this purpose. CLAIMS 1. A composition for antiviral use, said composition being obtained by the components selected from the group comprising 1-protopanaxatriol, methylpanaxadiol, methylprotobioside that are used individually or in combinations. 2. A composition according to Claim 1 characterized in that it comprises 20-32% by weight 1-protopanaxatriol. 3. A composition according to Claim 1 characterized in that it comprises 30-47% by weight methylpanaxadiol. 4. A composition according to Claim 1 characterized in that it comprises 50-21% by weight methylprotobioside. 5. Use of the components according to Claims 1 to 4 obtained individually or in combinations from the group consisting of 1-protopanaxatriol, methylpanaxadiol, methylprotobioside for the manufacture of an antiviral composition.